Background
Methods
Study information
Diagnostic criteria
Clinical diagnosis
Clinical data
Blood culture
Antibiotic sensitivity analysis
Statistical analysis
Results
General information
Pathogens distribution
Bacteria | Name | Cases | Percentage |
---|---|---|---|
Gram-positive bacteria | 74 | 76.3% | |
Kocuria varians
| 1 | 1.0% | |
S. epidermidis
| 43 | 44.3% | |
L. Monocytogenes
| 1 | 1.0% | |
E. faecalis
| 1 | 1.0% | |
S. aureus
| 2 | 2.1% | |
S. equorum
| 1 | 1.0% | |
S. simulans
| 1 | 1.0% | |
S. bovis
| 1 | 1.0% | |
S. hominis
| 8 | 8.2% | |
S. haemolyticus
| 14 | 14.4% | |
S. warneri
| 1 | 1.0% | |
Gram-negative bacteria | 19 | 19.6% | |
E. coli
| 6 | 6.2% | |
Klebsiella pneumoniae subsp.
| 10 | 10.3% | |
S. monad
| 1 | 1.0% | |
E. cloacae
| 2 | 2.1% | |
Fungi | 4 | 4.1% | |
C. albicans
| 1 | 1.0% | |
C. glabrata
| 2 | 2.1% | |
C. tropicalis
| 1 | 1.0% |
Drug resistance in pathogens
S. epidermidis | S. haemolyticus | Other 17 strains | Sum | |
---|---|---|---|---|
Penicillin | 95.3 (41/43) | 100.0 (14/14) | 82.4 (14/17) | 93.2 (69/74) |
Oxacillin | 83.7 (36/43) | 92.9 (13/14) | 80.0 (12/15)a
| 84.7 (61/72) |
Erythromycin | 67.4 (29/43) | 100.0 (14/14) | 100.0 (17/17) | 81.1 (60/74) |
Levofloxacin | 28.6 (10/35)a
| 81.8 (9/11)a
| 14.3 (2/14)a
| 35.0 (21/60) |
Vancomycin | 0.0 (0/43) | 0.0 (0/14) | 0 (0/17) | 0.0 (0/74) |
Rifampicin | 7.0 (3/43) | 7.1 (1/14) | 5.9 (1/17) | 6.8 (5/74) |
Teicoplanin | 24.3 (9/37)a
| 33.3 (4/12)a
| 7.1 (1/14)a
| 22.2 (14/63) |
Ampicillin | 100.0 (5/5) | 100.0 (2/2)a
| 66.7 (2/3)a
| 90.0 (9/10) |
Gentamicin | 37.2 (16/43) | 85.7 (12/14) | 56.2 (9/16)a
| 50.7 (37/73) |
SMZ | 60.5 (26/43) | 57.1 (8/14) | 62.5 (10/16)a
| 60.3 (44/73) |
Fusidic acid | 10.7 (3/28)a
| 27.3 (3/11)a
| 27.3 (3/11)a
| 18.0 (9/50) |
Ciprofloxacin | 44.4 (4/9)a
| 66.7 (2/3)a
| 50.0 (2/4)a
| 50.0 (8/16) |
E. coli | Klebsiella pneumoniae subsp. | Others | Sum | |
---|---|---|---|---|
Gentamicin | 33.3 (2/6) | 40.0 (4/10) | 66.7 (2/3) | 42.1 (8/19) |
SMZ | 66.7 (4/6) | 50.0 (5/10) | 33.3 (1/3) | 52.6 (10/19) |
Amoxicillin | 83.3 (5/6) | 100.0 (7/7) | 100.0 (2/2) | 93.3 (14/15) |
Piperacillin | 50.0 (3/6) | 100.0 (7/7)a
| 66.7 (2/3) | 75.0 (12/16) |
Piperacillin/Tazobactam | 16.7 (1/6) | 80.0 (8/10) | 100.0 (2/2)a
| 61.1 (11/18) |
Cefoxitin | 33.3 (2/6) | 100.0 (7/7)a
| 100.0 (2/2)a
| 73.3 (11/15) |
Ceftazidime | 33.3 (2/6) | 100.0 (10/10) | 66.7 (2/3) | 73.7 (14/19) |
Cefepime | 33.3 (2/6) | 100.0 (10/10) | 66.7 (2/3) | 73.7 (14/19) |
Cefuroxime | 50.0 (3/6) | 100.0 (7/7) | 66.7 (2/3) | 75.0 (12/16) |
Meropenem | 0.0 (0/6) | 0.0 (0/7)a
| 50.0 (1/2)a
| 6.7 (1/15) |
Imipenem | 0.0 (0/6) | 30.0 (3/10) | 33.3 (1/3) | 21.1 (4/19) |
Amikacin | 0.0 (0/6) | 0.0 (0/10) | 0.0 (0/3) | 0.0 (0/19) |
Amoxicillin/clavulanate | 33.3 (2/6) | 100.0 (7/7)a
| 100.0 (2/2)a
| 73.3 (11/15) |
Cefalotin | 50.0 (3/6) | 70.0 (7/10) | 100.0 (2/2)a
| 66.7 (12/18) |
Cefotaxime | 33.3 (2/6) | 100.0 (7/7)a
| 66.7 (2/3) | 68.8 (11/16) |
Tobramycin | 50.0 (3/6) | 10.0 (1/10) | 100.0 (2/2) | 33.3 (6/18) |